Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 24

2022 December-2 - 251 articles

Cover Story: Androgen deprivation therapy (ADT) is the principal therapy for advanced prostate cancer. ADT controls tumor growth by rapidly altering the prostate tumor microenvironment and subsequently inducing cancer cell death. ADT induces vascular damage and thereby reduces intratumoral blood flow, but the mechanism has long been elusive. This work, for the first time, functionally defines TNF as the mediator of castration-induced vascular damage in prostate tumors. This pathological response to androgen deprivation—beginning with endothelial cell apoptosis and increased vessel permeability and culminating in hypoxia—indirectly contributes to prostate cancer regression. Since TNF is also a critical death receptor ligand for prostate epithelial cells, we propose that TNF is a multi-purpose, comprehensive signal that mediates prostate cancer regression following androgen deprivation. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (251)

  • Review
  • Open Access
13 Citations
5,604 Views
11 Pages

Best Supportive Care of the Patient with Oesophageal Cancer

  • Rita Carrilho Pichel,
  • Alexandra Araújo,
  • Vital Da Silva Domingues,
  • Jorge Nunes Santos and ,
  • Elga Freire,
  • Ana Sofia Mendes,
  • Raquel Romão and
  • António Araújo
  • + 3 authors+ 0 author

19 December 2022

Background: Oesophageal cancer patients have poor survival, and most are unfit for curative or systemic palliative treatment. This article aims to review the best supportive care for oesophageal cancer, focusing on the management of its most frequent...

(This article belongs to the Special Issue Quality of Life and Side Effects Management in Cancer Treatment)
  • Review
  • Open Access
24 Citations
5,651 Views
18 Pages

19 December 2022

Breast cancer (BC) is a heterogeneous disease that can be triggered by genetic alterations in mammary epithelial cells, leading to diverse disease outcomes in individual patients. The metabolic heterogeneity of BC enhances its ability to adapt to cha...

(This article belongs to the Special Issue Mitochondrial Functions in Cancer)
  • Article
  • Open Access
4 Citations
3,271 Views
16 Pages

Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian Cancer

  • Tomi Akinyemiju,
  • Ashwini Joshi,
  • April Deveaux,
  • Lauren E. Wilson and ,
  • Dandan Chen,
  • Clare Meernik,
  • Malcolm Bevel,
  • Jen Gathings,
  • Laura Fish and
  • Bryce B. Reeve
  • + 17 authors+ 12 authors

19 December 2022

Several proposed theoretical frameworks have defined the complex nature of healthcare access (HCA) [...]

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
15 Citations
3,951 Views
21 Pages

A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases

  • Julian Mangesius,
  • Stephanie Mangesius,
  • Matthias Demetz,
  • Christian Uprimny and ,
  • Gianpaolo Di Santo,
  • Malik Galijasevic,
  • Danijela Minasch,
  • Elke R. Gizewski,
  • Ute Ganswindt and
  • Johannes Kerschbaumer
  • + 8 authors+ 3 authors

19 December 2022

Radiation necrosis represents a potentially devastating complication after radiation therapy in brain tumors. The establishment of the diagnosis and especially the differentiation from progression and pseudoprogression with its therapeutic implicatio...

  • Review
  • Open Access
12 Citations
3,964 Views
10 Pages

19 December 2022

Intrahepatic cholangiocarcinoma (ICC) is a rare and aggressive malignancy. It originates from the bile ducts and is the second most common primary cancer of the liver. Surgery is considered the only curative treatment of ICC, offering the best chance...

  • Article
  • Open Access
3,591 Views
16 Pages

Comparing Genetic Risk and Clinical Risk Classification in Luminal-like Breast Cancer Patients Using a 23-Gene Classifier

  • Chi-Cheng Huang,
  • Ting-Hao Chen,
  • Liang-Chih Liu,
  • Chiun-Sheng Huang and ,
  • Ji-An Liang,
  • Yu-Chen Hsu,
  • Chia-Ming Hsieh,
  • Sean-Lin Huang,
  • Kuan-Hui Shih and
  • Ling-Ming Tseng
  • + 5 authors+ 0 author

19 December 2022

Background: A 23-gene classifier has been developed based on gene expression profiles of Taiwanese luminal-like breast cancer. We aim to stratify risk of relapse and identify patients who may benefit from adjuvant chemotherapy based on genetic model...

(This article belongs to the Special Issue Genomics and Bioinformatics Based Analysis of Cancer)
  • Article
  • Open Access
28 Citations
4,782 Views
21 Pages

A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum

  • Eduardo Sommella,
  • Valeria Capaci,
  • Michelangelo Aloisio,
  • Emanuela Salviati and ,
  • Pietro Campiglia,
  • Giuseppe Molinario,
  • Danilo Licastro,
  • Giovanni Di Lorenzo,
  • Federico Romano and
  • Blendi Ura
  • + 7 authors+ 2 authors

19 December 2022

Endometrial cancers (ECs) are mostly adenocarcinomas arising from the inner part of the uterus. The identification of serum biomarkers, either soluble or carried in the exosome, may be useful in making an early diagnosis. We used label-free quantific...

(This article belongs to the Special Issue Therapy for Human Endometrioid - Endometrial Carcinoma and Endometriosis)
  • Article
  • Open Access
16 Citations
3,344 Views
13 Pages

Integration of Clinical and CT-Based Radiomic Features for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Breast Cancer

  • Huei-Yi Tsai,
  • Tsung-Yu Tsai,
  • Chia-Hui Wu,
  • Wei-Shiuan Chung and ,
  • Jo-Ching Wang,
  • Jui-Sheng Hsu,
  • Ming-Feng Hou and
  • Ming-Chung Chou
  • + 3 authors+ 0 author

19 December 2022

The purpose of the present study was to examine the potential of a machine learning model with integrated clinical and CT-based radiomics features in predicting pathologic complete response (pCR) to neoadjuvant systemic therapy (NST) in breast cancer...

(This article belongs to the Special Issue Recent Advances in Oncology Imaging)
  • Review
  • Open Access
27 Citations
7,918 Views
33 Pages

Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises

  • Aikaterini Skorda,
  • Marie Lund Bay,
  • Sampsa Hautaniemi,
  • Alexandra Lahtinen and
  • Tuula Kallunki

19 December 2022

Ovarian cancer is the deadliest gynecological cancer, the high-grade serous ovarian carcinoma (HGSC) being its most common and most aggressive form. Despite the latest therapeutical advancements following the introduction of vascular endothelial grow...

(This article belongs to the Special Issue Kinase Signaling in Cancer)
  • Article
  • Open Access
18 Citations
4,273 Views
19 Pages

Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum

  • Norah A. Alturki,
  • Mutaib M. Mashraqi,
  • Khurshid Jalal,
  • Kanwal Khan and ,
  • Zarrin Basharat and
  • Ahmad Alzamami
  • + 1 author+ 0 author

19 December 2022

Colorectal cancer (CRC) ranks third among all cancers in terms of prevalence. There is growing evidence that gut microbiota has a role in the development of colorectal cancer. Fusobacterium nucleatum is overrepresented in the gastrointestinal tract a...

(This article belongs to the Special Issue Bacterial, Viral and Parasitic Pathogens and Colorectal Cancer)
  • Article
  • Open Access
9 Citations
5,502 Views
13 Pages

19 December 2022

Autologous stem cell transplantation is routinely used in the management of several hematological diseases, solid tumors, and immune disorders. Peripheral blood stem cell (PBSC) collection performed by apheresis is the preferred source of stem cells....

(This article belongs to the Special Issue Autologous Stem Cell Transplantation or New Cellular Therapies for Neoplasias)
  • Review
  • Open Access
11 Citations
6,616 Views
16 Pages

19 December 2022

The limited treatment options for triple-negative breast cancer with brain metastasis (TNBC-BM) have left the door of further drug development for these patients wide open. Although immunotherapy via monoclonal antibodies has shown some promising res...

(This article belongs to the Special Issue Immunotherapy of Triple-Negative Breast Cancer)
  • Article
  • Open Access
10 Citations
4,904 Views
26 Pages

19 December 2022

Cervical cancer is one of the leading causes of cancer deaths among women in low- and middle-income countries such as South Africa. The current impact of national cervical cancer control and sexual and reproductive health interventions in South Afric...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Review
  • Open Access
9 Citations
3,844 Views
20 Pages

An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22

  • Maria Laura Centomo,
  • Marianna Vitiello,
  • Laura Poliseno and
  • Pier Paolo Pandolfi

19 December 2022

MiR-22 was first identified as a proto-oncogenic microRNA (miRNA) due to its ability to post-transcriptionally suppress the expression of the potent PTEN (Phosphatase And Tensin Homolog) tumor suppressor gene. miR-22 tumorigenic role in cancer was su...

(This article belongs to the Collection miRNAs: New Insights in Tumor Biology)
  • Article
  • Open Access
14 Citations
3,777 Views
26 Pages

High-Frequency Nanosecond Bleomycin Electrochemotherapy and its Effects on Changes in the Immune System and Survival

  • Austėja Balevičiūtė,
  • Eivina Radzevičiūtė,
  • Augustinas Želvys,
  • Veronika Malyško-Ptašinskė and ,
  • Jurij Novickij,
  • Auksė Zinkevičienė,
  • Vytautas Kašėta,
  • Vitalij Novickij and
  • Irutė Girkontaitė
  • + 4 authors+ 0 author

19 December 2022

In this work, a time-dependent and time-independent study on bleomycin-based high-frequency nsECT (3.5 kV/cm × 200 pulses) for the elimination of LLC1 tumours in C57BL/6J mice is performed. We show the efficiency of nsECT (200 ns and 700 ns del...

(This article belongs to the Special Issue Electroporation-Based Cancer Treatment. Selected Papers from the 4th World Congress on Electroporation)
  • Article
  • Open Access
22 Citations
4,131 Views
13 Pages

Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection

  • Mahdi Zirakchian Zadeh,
  • Randy Yeh,
  • Henry S. Kunin,
  • Assen S. Kirov and ,
  • Elena N. Petre,
  • Mithat Gönen,
  • Mikhail Silk,
  • Francois H. Cornelis,
  • Kevin C. Soares and
  • Constantinos T. Sofocleous
  • + 8 authors+ 3 authors

19 December 2022

Background: Real-time split-dose PET can identify the targeted colorectal liver metastasis (CLM) and eliminate the need for repeated contrast administration before and during thermal ablation (TA). This study aimed to assess the added value of pre-ab...

(This article belongs to the Special Issue Management of Colorectal Cancer Metastatic Disease)
  • Review
  • Open Access
24 Citations
5,310 Views
23 Pages

The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review

  • Sandrine Pereira,
  • Ester Orlandi,
  • Sophie Deneuve,
  • Amelia Barcellini and ,
  • Agnieszka Chalaszczyk,
  • Isabelle Behm-Ansmant,
  • Liza Hettal,
  • Tiziana Rancati,
  • Guillaume Vogin and
  • Juliette Thariat
  • + 5 authors+ 0 author

19 December 2022

(1) Background: radiotherapy is a cornerstone of cancer treatment. When delivering a tumoricidal dose, the risk of severe late toxicities is usually kept below 5% using dose-volume constraints. However, individual radiation sensitivity (iRS) is respo...

(This article belongs to the Special Issue Personalized Radiation Therapy for Oncology)
  • Systematic Review
  • Open Access
26 Citations
4,434 Views
19 Pages

Current Knowledge on Spinal Meningiomas Epidemiology, Tumor Characteristics and Non-Surgical Treatment Options: A Systematic Review and Pooled Analysis (Part 1)

  • Victor Gabriel El-Hajj,
  • Jenny Pettersson-Segerlind,
  • Alexander Fletcher-Sandersjöö,
  • Erik Edström and
  • Adrian Elmi-Terander

19 December 2022

Background: Spinal meningiomas are the most common primary intradural spinal tumors. Although they are a separate entity, a large portion of the knowledge on spinal meningiomas is based on findings in intracranial meningiomas. Therefore, a comprehens...

(This article belongs to the Special Issue Meningioma Surgery and Functional Outcome)
  • Article
  • Open Access
31 Citations
4,249 Views
17 Pages

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

  • Anna Grenda,
  • Ewelina Iwan,
  • Paweł Krawczyk,
  • Małgorzata Frąk and ,
  • Izabela Chmielewska,
  • Arkadiusz Bomba,
  • Aleksandra Giza,
  • Anna Rolska-Kopińska,
  • Michał Szczyrek and
  • Janusz Milanowski
  • + 9 authors+ 4 authors

19 December 2022

Introduction: Factors other than PD-L1 (Programmed Death Ligand 1) are being sought as predictors for cancer immuno- or chemoimmunotherapy in ongoing studies and long-term observations. Despite high PD-L1 expression on tumor cells, some patients do n...

(This article belongs to the Special Issue Current Challenge and Future Advances for Lung Cancer: Genetics, Instrumental Diagnosis and Treatment)
  • Article
  • Open Access
16 Citations
4,959 Views
11 Pages

Central Nervous System Metastasis in Neuroblastoma: From Three Decades Clinical Experience to New Considerations in the Immunotherapy Era

  • Angela Mastronuzzi,
  • Giovanna Stefania Colafati,
  • Andrea Carai,
  • Maria D’Egidio and ,
  • Francesco Fabozzi,
  • Francesca Del Bufalo,
  • Maria Felicia Villani,
  • Giada Del Baldo,
  • Sabina Vennarini and
  • Maria Antonietta De Ioris
  • + 9 authors+ 4 authors

19 December 2022

Central nervous system (CNS) metastatic spread in neuroblastoma (NB) is rare and occurs more often at relapse/progression. We report on CNS involvement in high risk (HR) NB over 25 years. For this retrospective study, we reviewed the CNS imaging of a...

(This article belongs to the Section Pediatric Oncology)
  • Article
  • Open Access
11 Citations
6,542 Views
14 Pages

High-Dose-Rate Brachytherapy as an Organ-Sparing Treatment for Early Penile Cancer

  • Denisa Pohanková,
  • Igor Sirák,
  • Milan Vošmik,
  • Linda Kašaová and ,
  • Jakub Grepl,
  • Petr Paluska,
  • Lukáš Holub,
  • Jiří Špaček,
  • Miroslav Hodek and
  • Jiří Petera
  • + 6 authors+ 1 author

19 December 2022

Background: Low-dose-rate brachytherapy is an effective organ-sparing treatment for patients with early-stage penile cancer. However, only limited data are available on the role of high-dose-rate brachytherapy (HDR-BT) in this clinical setting. Metho...

(This article belongs to the Special Issue Advances in Brachytherapy in the Treatment of Tumors)
  • Article
  • Open Access
10 Citations
3,366 Views
18 Pages

Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth

  • Chandrani Chattopadhyay,
  • Rajat Bhattacharya,
  • Jason Roszik,
  • Fatima S. Khan and ,
  • Gabrielle A. Wells,
  • Hugo Villanueva,
  • Yong Qin,
  • Rishav Bhattacharya,
  • Sapna P. Patel and
  • Elizabeth A. Grimm
  • + 5 authors+ 0 author

19 December 2022

Uveal melanoma originating in the eye and metastasizing to the liver is associated with poor prognosis and has only one approved therapeutic option. We hypothesized that liver-borne growth factors may contribute to UM growth. Therefore, we investigat...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
72 Citations
9,146 Views
28 Pages

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets

  • Kharimat Lora Alatise,
  • Samantha Gardner and
  • Angela Alexander-Bryant

18 December 2022

In the United States, over 100,000 women are diagnosed with a gynecologic malignancy every year, with ovarian cancer being the most lethal. One of the hallmark characteristics of ovarian cancer is the development of resistance to chemotherapeutics. W...

  • Review
  • Open Access
10 Citations
4,575 Views
20 Pages

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact

  • Piera Federico,
  • Emilio Francesco Giunta,
  • Andrea Tufo,
  • Francesco Tovoli and ,
  • Angelica Petrillo and
  • Bruno Daniele
  • + 1 author+ 0 author

18 December 2022

Antiangiogenic drugs were the only mainstay of advanced hepatocellular carcinoma (HCC) treatment from 2007 to 2017. However, primary or secondary resistance hampered their efficacy. Primary resistance could be due to different molecular and/or geneti...

(This article belongs to the Special Issue Immune Checkpoint and Novel Perspectives in the Management of Hepatocellular Carcinoma)
  • Article
  • Open Access
5 Citations
2,453 Views
11 Pages

Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component

  • Victoria Platte,
  • Anika Bergmann,
  • Barbara Hildebrandt,
  • Dagmar Wieczorek and ,
  • Esther Schuler,
  • Ulrich Germing,
  • Jennifer Kaivers,
  • Rainer Haas,
  • Guido Kobbe and
  • Christina Rautenberg
  • + 6 authors+ 1 author

18 December 2022

An improved understanding of relapse kinetics is required to optimize detection and treatment strategies for the post-transplant relapse of myeloid neoplasms. Therefore, we retrospectively analyzed data from 91 patients allografted for MDS (n = 54),...

(This article belongs to the Special Issue Recent Advances in Myelodysplastic Syndromes: Diagnosis, Prognosis and Clinical Therapy)
  • Article
  • Open Access
6 Citations
3,666 Views
15 Pages

Anastomotic Leakage after Colorectal Surgery in Ovarian Cancer: Drainage, Stoma Utility and Risk Factors

  • Liliana Mereu,
  • Francesca Dalprà,
  • Valeria Berlanda,
  • Riccardo Pertile and ,
  • Daniela Coser,
  • Basilio Pecorino,
  • Maria Gabriella D’Agate,
  • Francesco Ciarleglio,
  • Alberto Brolese and
  • Saverio Tateo
  • + 5 authors+ 0 author

18 December 2022

Objective: to evaluate the incidence of anastomotic leakage (AL), risk factors and utility of drainage and stoma in patients undergoing intestinal surgery for ovarian cancer in a single institution and in a review of the literature. Methods: retrospe...

(This article belongs to the Collection Innovative Concepts in the Diagnosis and Treatment of Gynecologic Malignancies)
  • Article
  • Open Access
2 Citations
2,523 Views
11 Pages

Predictive Value of 18F-Fluorodeoxyglucose Positron-Emission Tomography Metabolic and Volumetric Parameters for Systemic Metastasis in Tonsillar Cancer

  • Jooin Bang,
  • Hye Lim Park,
  • Ie Ryung Yoo,
  • Hyun-Il Shin and ,
  • Geun-Jeon Kim,
  • Dong-Il Sun and
  • Sang-Yeon Kim
  • + 2 authors+ 0 author

18 December 2022

Although the prognosis of tonsillar cancer (human papillomavirus-positive oropharyngeal squamous cell carcinoma) is improving, disease control failure (distant metastasis) still occurs in some cases. We explored whether several 18F-fluorodeoxyglucose...

  • Article
  • Open Access
3 Citations
2,680 Views
14 Pages

Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients

  • Vincent Vinh-Hung,
  • Olena Gorobets,
  • Nele Adriaenssens,
  • Hilde Van Parijs and ,
  • Guy Storme,
  • Dirk Verellen,
  • Nam P. Nguyen,
  • Nicolas Magne and
  • Mark De Ridder
  • + 4 authors+ 0 author

18 December 2022

We investigated lung-heart toxicity and mortality in 123 women with stage I-II breast cancer enrolled in 2007–2011 in a prospective trial of adjuvant radiotherapy (TomoBreast). We were concerned whether the COVID-19 pandemic affected the outcom...

  • Article
  • Open Access
9 Citations
4,642 Views
16 Pages

Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML

  • Debbie C. Strachan,
  • Christine J. Gu,
  • Ryosuke Kita,
  • Erica K. Anderson and ,
  • Michelle A. Richardson,
  • George Yam,
  • Graham Pimm,
  • Jordan Roselli,
  • Alyssa Schweickert and
  • Alexandra M. Stevens
  • + 14 authors+ 9 authors

18 December 2022

Acute myeloid leukemia (AML) is a heterogeneous disease that accounts for ~20% of all childhood leukemias, and more than 40% of children with AML relapse within three years of diagnosis. Although recent efforts have focused on developing a precise me...

(This article belongs to the Section Pediatric Oncology)
  • Article
  • Open Access
34 Citations
4,284 Views
13 Pages

Different Oncologic Outcomes in Early-Onset and Late-Onset Sporadic Colorectal Cancer: A Regression Analysis on 2073 Patients

  • Caterina Foppa,
  • Annalisa Maroli,
  • Sara Lauricella,
  • Antonio Luberto and ,
  • Carlotta La Raja,
  • Francesca Bunino,
  • Michele Carvello,
  • Matteo Sacchi,
  • Francesca De Lucia and
  • Antonino Spinelli
  • + 7 authors+ 2 authors

18 December 2022

The incidence of colorectal cancer (CRC) is increasing in the population aged ≤ 49 (early-onset CRC-EOCRC). Recent studies highlighted the biological and clinical differences between EOCRC and late-onset CRC (LOCRC-age ≥ 50), while comparative...

(This article belongs to the Special Issue Early Onset Colorectal Cancer: Epidemiology and Etiology)
  • Article
  • Open Access
6 Citations
2,814 Views
14 Pages

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

  • Masoud Karimi,
  • Pia Osterlund,
  • Klara Hammarström,
  • Israa Imam and ,
  • Jan-Erik Frodin and
  • Bengt Glimelius
  • + 1 author+ 0 author

18 December 2022

Complete pathological response (pCR) is achieved in 10–20% of rectal cancers when treated with short-course radiotherapy (scRT) or long-course chemoradiotherapy (CRT) and in 28% with total neoadjuvant therapy (scRT/CRT + CTX). pCR is associated...

(This article belongs to the Special Issue The Survival of Colon and Rectal Cancer)
  • Article
  • Open Access
23 Citations
3,275 Views
12 Pages

Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy

  • Corrado Tinterri,
  • Andrea Sagona,
  • Erika Barbieri,
  • Simone Di Maria Grimaldi and ,
  • Flavia Jacobs,
  • Alberto Zambelli,
  • Rubina Manuela Trimboli,
  • Daniela Bernardi,
  • Valeriano Vinci and
  • Damiano Gentile
  • + 5 authors+ 0 author

17 December 2022

Background: Loco-regional therapy (LRT) in de novo metastatic breast cancer (MBC) has been investigated in several clinical trials, with heterogeneous and conflicting results. Methods: We conducted a retrospective study of de novo MBC patients treate...

(This article belongs to the Special Issue Breast Cancer Metastasis: Novel Insights into Molecular Mechanisms and Treatments)
  • Article
  • Open Access
17 Citations
3,615 Views
14 Pages

Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer

  • Wakako Daido,
  • Takeshi Masuda,
  • Nobuki Imano,
  • Naoko Matsumoto and ,
  • Kosuke Hamai,
  • Yasuo Iwamoto,
  • Yusuke Takayama,
  • Sayaka Ueno,
  • Masahiko Sumii and
  • Noboru Hattori
  • + 16 authors+ 11 authors

17 December 2022

Introduction/Background: Chemoradiotherapy (CRT) followed by durvalumab, an immune checkpoint inhibitor, is the standard treatment for locally advanced non-small-cell lung cancer (NSCLC). Interstitial lung disease (ILD) is a life-threatening toxicity...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
16 Citations
4,776 Views
14 Pages

Using Whole Slide Gray Value Map to Predict HER2 Expression and FISH Status in Breast Cancer

  • Qian Yao,
  • Wei Hou,
  • Kaiyuan Wu,
  • Yanhua Bai and ,
  • Mengping Long,
  • Xinting Diao,
  • Ling Jia,
  • Dongfeng Niu and
  • Xiang Li
  • + 4 authors+ 0 author

17 December 2022

Accurate detection of HER2 expression through immunohistochemistry (IHC) is of great clinical significance in the treatment of breast cancer. However, manual interpretation of HER2 is challenging, due to the interobserver variability among pathologis...

(This article belongs to the Topic Artificial Intelligence in Cancer Diagnosis and Therapy)
  • Article
  • Open Access
28 Citations
4,879 Views
13 Pages

Metabolic Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study

  • Samuel O. Antwi,
  • Emily C. Craver,
  • Yvonne A. Nartey,
  • Kurt Sartorius and
  • Tushar Patel

17 December 2022

Non-alcoholic fatty liver disease (NAFLD) is a fast-growing public health problem and predisposes to hepatocellular carcinoma (HCC) in a significant proportion of patients. Metabolic alterations might underlie the progression of NAFLD to HCC, but the...

(This article belongs to the Special Issue Gastrointestinal Tract Cancers, an Increasing Burden of the Modern Era: Epidemiology and Prevention)
  • Article
  • Open Access
15 Citations
3,652 Views
18 Pages

Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma

  • Hedda J. van der Hulst,
  • Joris L. Vos,
  • Renaud Tissier,
  • Laura A. Smit and ,
  • Roland M. Martens,
  • Regina G. H. Beets-Tan,
  • Michiel W. M. van den Brekel,
  • Charlotte L. Zuur and
  • Jonas A. Castelijns
  • + 4 authors+ 0 author

17 December 2022

Background: Neoadjuvant immune checkpoint blockade (ICB) prior to surgery may induce early pathological responses in head and neck squamous cell carcinoma (HNSCC) patients. Routine imaging parameters fail to diagnose these responses early on. Magneti...

  • Article
  • Open Access
16 Citations
3,089 Views
15 Pages

Preoperative Cancer Inflammation Prognostic Index as a Superior Predictor of Short- and Long-Term Outcomes in Patients with Stage I–III Colorectal Cancer after Curative Surgery

  • Jeng-Fu You,
  • Yu-Jen Hsu,
  • Yih-Jong Chern,
  • Ching-Chung Cheng and ,
  • Bor-Kang Jong,
  • Chun-Kai Liao,
  • Pao-Shiu Hsieh,
  • Hung-Chih Hsu and
  • Wen-Sy Tsai
  • + 4 authors+ 0 author

17 December 2022

Inflammatory reactions play a crucial role in cancer progression and may contribute to systemic inflammation. In routine clinical practice, some inflammatory biomarkers can be utilized as valuable predictors for colorectal cancer (CRC). This study ai...

  • Review
  • Open Access
23 Citations
3,956 Views
19 Pages

Diagnostic and Prognostic Deep Learning Applications for Histological Assessment of Cutaneous Melanoma

  • Sydney R. Grant,
  • Tom W. Andrew,
  • Eileen V. Alvarez,
  • Wendy J. Huss and
  • Gyorgy Paragh

17 December 2022

Melanoma is among the most devastating human malignancies. Accurate diagnosis and prognosis are essential to offer optimal treatment. Histopathology is the gold standard for establishing melanoma diagnosis and prognostic features. However, discrepanc...

  • Review
  • Open Access
11 Citations
3,635 Views
16 Pages

Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade

  • Mathieu Larroquette,
  • Félix Lefort,
  • Luc Heraudet,
  • Jean-Christophe Bernhard and ,
  • Alain Ravaud,
  • Charlotte Domblides and
  • Marine Gross-Goupil
  • + 2 authors+ 0 author

17 December 2022

Clear cell renal cell carcinoma (RCC) oncogenesis is mainly driven by VHL gene inactivation, leading to overexpression of vascular endothelial growth factor (VEGF). The use of tyrosine-kinase inhibitors (TKIs) directed against VEGF and its receptor (...

(This article belongs to the Special Issue Novel Therapeutics for Genitourinary Tumors)
  • Article
  • Open Access
10 Citations
3,156 Views
12 Pages

Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells

  • Mohammed Khurshed,
  • Elia Prades-Sagarra,
  • Sarah Saleh,
  • Peter Sminia and ,
  • Johanna W. Wilmink,
  • Remco J. Molenaar,
  • Hans Crezee and
  • Cornelis J. F. van Noorden
  • + 3 authors+ 0 author

17 December 2022

Mutations in the isocitrate dehydrogenase 1 (IDH1MUT) gene occur in various types of malignancies, including ~60% of chondrosarcomas, ~30% of intrahepatic cholangiocarcinomas and >80% of low-grade gliomas. IDH1MUT are causal in the development and...

(This article belongs to the Collection Hyperthermia in Cancer Therapy)
  • Article
  • Open Access
4 Citations
3,170 Views
11 Pages

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers

  • Kyo Togashi,
  • Shingo Hatakeyama,
  • Osamu Soma,
  • Kazutaka Okita and ,
  • Naoki Fujita,
  • Toshikazu Tanaka,
  • Daisuke Noro,
  • Hirotaka Horiguchi,
  • Nozomi Uemura and
  • Chikara Ohyama
  • + 10 authors+ 5 authors

17 December 2022

Background: The estimation of biological age is challenging in patients with cancers. We aimed to investigate frailty-based biological ages using frailty-discriminant scores (FDS) and examined the effect of biological-expected life age discrepancy on...

(This article belongs to the Special Issue Sarcopenia and Frailty as a Prognostic/Outcome Biomarker of Urological Cancer Patients)
  • Article
  • Open Access
11 Citations
4,636 Views
22 Pages

Correlation between DNA Methylation and Cell Proliferation Identifies New Candidate Predictive Markers in Meningioma

  • Sébastien Hergalant,
  • Chloé Saurel,
  • Marion Divoux,
  • Fabien Rech and ,
  • Celso Pouget,
  • Catherine Godfraind,
  • Pierre Rouyer,
  • Stéphanie Lacomme,
  • Shyue-Fang Battaglia-Hsu and
  • Guillaume Gauchotte
  • + 5 authors+ 0 author

17 December 2022

Meningiomas are the most common primary tumors of the central nervous system. Based on the 2021 WHO classification, they are classified into three grades reflecting recurrence risk and aggressiveness. However, the WHO’s histopathological criter...

(This article belongs to the Special Issue Predictive and Prognostic Markers in Brain Tumors: From Physiopathology to Clinical Applications)
  • Article
  • Open Access
11 Citations
4,424 Views
10 Pages

Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients

  • Francesca Torresan,
  • Simona Censi,
  • Gianmaria Pennelli,
  • Francesca Galuppini and ,
  • Caterina Mian and
  • Maurizio Iacobone
  • + 1 author+ 0 author

17 December 2022

Prophylactic and early thyroidectomy in RET germline mutation carriers allows the removal of the thyroid before medullary thyroid carcinoma (MTC) develops, or while it is still confined to the gland. This study was aimed to assess the clinicopatholog...

  • Article
  • Open Access
16 Citations
5,977 Views
11 Pages

A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [177Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial

  • Dongho Shin,
  • Seunggyun Ha,
  • Joo Hyun O,
  • Seung ah Rhew and ,
  • Chang Eil Yoon,
  • Hyeok Jae Kwon,
  • Hyong Woo Moon,
  • Yong Hyun Park,
  • Sonya Youngju Park and
  • Ji Youl Lee
  • + 8 authors+ 3 authors

16 December 2022

[177Lu]Ludotadipep, which enables targeted delivery of beta-particle radiation to prostate tumor cells, had been suggested as a promising therapeutic option for mCRPC. From November 2020 to March 2022, a total of 30 patients were enrolled for single...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume)
  • Article
  • Open Access
12 Citations
3,306 Views
12 Pages

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling

  • Ricarda Hinzpeter,
  • Roshini Kulanthaivelu,
  • Andres Kohan,
  • Lisa Avery and ,
  • Nhu-An Pham,
  • Claudia Ortega,
  • Ur Metser,
  • Masoom Haider and
  • Patrick Veit-Haibach
  • + 4 authors+ 0 author

16 December 2022

We investigate whether computed tomography (CT) derived radiomics may correlate with driver gene mutations in patients with pancreatic ductal adenocarcinoma (PDAC). In this retrospective study, 47 patients (mean age 64 ± 11 years; range: 42&nd...

(This article belongs to the Special Issue Advances in Diagnosis and Treatment of Pancreatic Cancer)
  • Article
  • Open Access
29 Citations
3,988 Views
22 Pages

Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma

  • Ludwika Piwowarczyk,
  • Dariusz T. Mlynarczyk,
  • Violetta Krajka-Kuźniak,
  • Aleksandra Majchrzak-Celińska and ,
  • Anna Budzianowska,
  • Szymon Tomczak,
  • Jaromir Budzianowski,
  • Aneta Woźniak-Braszak,
  • Rafał Pietrzyk and
  • Anna Jelinska
  • + 7 authors+ 2 authors

16 December 2022

Glioblastoma (GBM) is the most common malignant neoplasm in adults among all CNS gliomas, with the 5-year survival rate being as low as 5%. Among nanocarriers, liposomal nanoformulations are considered as a promising tool for precise drug delivery. T...

  • Review
  • Open Access
23 Citations
6,531 Views
15 Pages

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

  • Brandon M. Huffman,
  • Haley Ellis,
  • Alexander C. Jordan,
  • William A. Freed-Pastor and ,
  • Kimberly Perez,
  • Douglas A. Rubinson,
  • Nilay Sethi,
  • Harshabad Singh,
  • Rishi Surana and
  • James M. Cleary
  • + 7 authors+ 2 authors

16 December 2022

The aggressive biology of pancreatic ductal adenocarcinoma (PDAC), along with its limited sensitivity to many systemic therapies, presents a major challenge in the management of patients with metastatic PDAC. Over the past decade, the incorporation o...

(This article belongs to the Collection Recent Advances in Pancreatic Ductal Adenocarcinoma)
  • Systematic Review
  • Open Access
30 Citations
4,562 Views
26 Pages

Current Knowledge on Spinal Meningiomas—Surgical Treatment, Complications, and Outcomes: A Systematic Review and Meta-Analysis (Part 2)

  • Victor Gabriel El-Hajj,
  • Jenny Pettersson-Segerlind,
  • Alexander Fletcher-Sandersjöö,
  • Erik Edström and
  • Adrian Elmi-Terander

16 December 2022

Background: Most of the knowledge on spinal meningiomas is extrapolated from their intracranial counterparts, even though they are considered separate entities. This review aimed to systematically summarize studies covering different aspects of spina...

(This article belongs to the Special Issue Meningioma Surgery and Functional Outcome)
  • Article
  • Open Access
9 Citations
3,735 Views
13 Pages

The Lymphatic System, Lymphoedema, and Medical Curricula–Survey of Australian Medical Graduates

  • Natalie Kruger,
  • Melanie L. Plinsinga,
  • Rhian Noble-Jones,
  • Neil Piller and ,
  • Vaughan Keeley and
  • Sandra C. Hayes
  • + 1 author+ 0 author

16 December 2022

The aim of this study was to survey the perceptions of recent (i.e., within the past 12 months) Australian medical graduates regarding (i) their understanding of the lymphatic system and lymphoedema, and (ii) the extent to which the lymphatic system...

(This article belongs to the Special Issue New Insights in Lymphedema after Cancer to Enhance Clinical Practice)
  • Article
  • Open Access
43 Citations
3,238 Views
23 Pages

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma

  • Donghong Yang,
  • Meilian Liu,
  • Junhong Jiang,
  • Yiping Luo and ,
  • Yongcun Wang,
  • Huoguang Chen,
  • Dongbing Li,
  • Dongliang Wang,
  • Zhixiong Yang and
  • Hualin Chen
  • + 5 authors+ 0 author

16 December 2022

Doublesex and Mab-3 related Transcription Factor 3 (DMRT3) is associated with the prognosis of some tumors. It is possible to explore the role of DMRT3 in the cancer process using bioinformatic approaches and experimental validation. We comprehensive...

(This article belongs to the Collection Application of Bioinformatics in Cancers)

of 6

XFacebookLinkedIn
Cancers - ISSN 2072-6694